U.S. biosimilar competition, use, and availability still lags behind European countries | MDedge

Concept	Lead	score
Biologic Therapy	1	1
Biosimilars	0	0.99
Europe	0	0.33
Drug Costs	0	0.28
Face	0	0.05
Health Care Cost	0	0.05

Specialty	Lead	score
Pharmacist	1	1